(CNS) Cohen & Steers - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US19247A1007

Stock: Real Estate, Infrastructure, Preferred Securities, Commodities, Multi-Strategy

Total Rating 37
Risk 84
Buy Signal -0.70

EPS (Earnings per Share)

EPS (Earnings per Share) of CNS over the last years for every Quarter: "2020-12": 0.76, "2021-03": 0.79, "2021-06": 0.94, "2021-09": 1.06, "2021-12": 1.24, "2022-03": 1.04, "2022-06": 0.96, "2022-09": 0.92, "2022-12": 0.79, "2023-03": 0.76, "2023-06": 0.7, "2023-09": 0.7, "2023-12": 0.67, "2024-03": 0.7, "2024-06": 0.68, "2024-09": 0.77, "2024-12": 0.78, "2025-03": 0.75, "2025-06": 0.73, "2025-09": 0.81, "2025-12": 0.81,

Revenue

Revenue of CNS over the last years for every Quarter: 2020-12: 117.086, 2021-03: 126.363, 2021-06: 144.269, 2021-09: 154.187, 2021-12: 159.629, 2022-03: 154.189, 2022-06: 147.431, 2022-09: 139.951, 2022-12: 127.827, 2023-03: 126.082, 2023-06: 124.058, 2023-09: 123.737, 2023-12: 123.399, 2024-03: 126.629, 2024-06: 126.778, 2024-09: 138.623, 2024-12: 144.731, 2025-03: 139.838, 2025-06: 142.441, 2025-09: 141.72, 2025-12: 143.803,

Dividends

Dividend Yield 3.25%
Yield on Cost 5y 4.25%
Yield CAGR 5y -1.17%
Payout Consistency 84.1%
Payout Ratio 80.0%
Risk 5d forecast
Volatility 30.7%
Relative Tail Risk -4.90%
Reward TTM
Sharpe Ratio -1.02
Alpha -41.49
Character TTM
Beta 0.929
Beta Downside 0.637
Drawdowns 3y
Max DD 42.59%
CAGR/Max DD -0.05

Description: CNS Cohen & Steers January 11, 2026

Cohen & Steers, Inc. (NYSE:CNS) is a publicly-owned asset-management holding company that channels its subsidiaries’ capabilities into a suite of investment products for institutional clients such as pension funds, endowments and foundations. Its platform delivers separate-account equity, fixed-income, multi-asset and commodity portfolios, as well as a range of mutual funds and hedge funds that target real-asset-heavy strategies.

Since its founding in 1986 and headquartered in New York, the firm has positioned itself as a specialist in “real assets” – notably real-estate investment trusts (REITs), infrastructure, natural-energy resources and preferred securities. In 2023 the company reported roughly $71 billion in assets under management (AUM), with preferred-security assets growing at an estimated 9 % CAGR over the past five years, reflecting strong investor demand for yield in a low-interest-rate environment.

Key economic drivers for Cohen & Steers include the trajectory of U.S. interest rates (which directly affect the pricing and demand for preferred securities), inflation trends (which bolster the appeal of real-asset exposure as an inflation hedge), and global real-estate cycles that influence REIT performance. A recent sector-level base-rate analysis shows that U.S. REITs have outperformed the broader equity market by an average of 1.2 percentage points over the past 12 months, providing a tailwind for the firm’s core business.

For a deeper quantitative breakdown, you might explore ValueRay’s analyst portal to see how CNS’s valuation metrics compare with peers.

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income: 144.9m TTM > 0 and > 6% of Revenue
FCF/TA: -0.12 > 0.02 and ΔFCF/TA -24.00 > 1.0
NWC/Revenue: 51.75% < 20% (prev 69.04%; Δ -17.30% < -1%)
CFO/TA -0.11 > 3% & CFO -86.7m > Net Income 144.9m
Net Debt (140.3m) to EBITDA (200.4m): 0.70 < 3
Current Ratio: 5.04 > 1.5 & < 3
Outstanding Shares: last quarter (51.6m) vs 12m ago -0.13% < -2%
Gross Margin: 57.51% > 18% (prev 0.49%; Δ 5702 % > 0.5%)
Asset Turnover: 70.36% > 50% (prev 66.07%; Δ 4.29% > 0%)
Interest Coverage Ratio: -12.46 > 6 (EBITDA TTM 200.4m / Interest Expense TTM -15.2m)

Altman Z'' 3.54

A: 0.37 (Total Current Assets 366.6m - Total Current Liabilities 72.8m) / Total Assets 801.6m
B: -0.14 (Retained Earnings -108.3m / Total Assets 801.6m)
C: 0.23 (EBIT TTM 189.4m / Avg Total Assets 807.0m)
D: 0.0 (Book Value of Equity 0.0 / Total Liabilities 222.4m)
Altman-Z'' Score: 3.54 = A

What is the price of CNS shares?

As of February 07, 2026, the stock is trading at USD 62.71 with a total of 130,216 shares traded.
Over the past week, the price has changed by -2.41%, over one month by -5.77%, over three months by -6.87% and over the past year by -27.47%.

Is CNS a buy, sell or hold?

Cohen & Steers has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CNS.
  • StrongBuy: 1
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the CNS price?

Issuer Target Up/Down from current
Wallstreet Target Price 72 14.8%
Analysts Target Price 72 14.8%
ValueRay Target Price 61.9 -1.4%

CNS Fundamental Data Overview February 02, 2026

P/E Trailing = 21.7095
P/E Forward = 19.3798
P/S = 5.894
P/B = 5.986
P/EG = 1.0154
Revenue TTM = 567.8m USD
EBIT TTM = 189.4m USD
EBITDA TTM = 200.4m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 140.3m USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 140.3m USD (using Total Debt 140.3m, CCE unavailable)
Enterprise Value = 3.42b USD (3.28b + Debt 140.3m - (null CCE))
Interest Coverage Ratio = -12.46 (Ebit TTM 189.4m / Interest Expense TTM -15.2m)
EV/FCF = -36.34x (Enterprise Value 3.42b / FCF TTM -94.0m)
FCF Yield = -2.75% (FCF TTM -94.0m / Enterprise Value 3.42b)
FCF Margin = -16.56% (FCF TTM -94.0m / Revenue TTM 567.8m)
Net Margin = 25.51% (Net Income TTM 144.9m / Revenue TTM 567.8m)
Gross Margin = 57.51% ((Revenue TTM 567.8m - Cost of Revenue TTM 241.3m) / Revenue TTM)
Gross Margin QoQ = 82.15% (prev 48.12%)
Tobins Q-Ratio = 4.26 (Enterprise Value 3.42b / Total Assets 801.6m)
Interest Expense / Debt = 0.36% (Interest Expense 503.0k / Debt 140.3m)
Taxrate = 27.40% (11.6m / 42.3m)
NOPAT = 137.5m (EBIT 189.4m * (1 - 27.40%))
Current Ratio = 5.04 (Total Current Assets 366.6m / Total Current Liabilities 72.8m)
Debt / Equity = 0.25 (Debt 140.3m / totalStockholderEquity, two quarters ago 550.3m)
Debt / EBITDA = 0.70 (Net Debt 140.3m / EBITDA 200.4m)
Debt / FCF = -1.49 (negative FCF - burning cash) (Net Debt 140.3m / FCF TTM -94.0m)
Total Stockholder Equity = 524.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 17.95% (Net Income 144.9m / Total Assets 801.6m)
RoE = 27.62% (Net Income TTM 144.9m / Total Stockholder Equity 524.5m)
RoCE = 25.99% (EBIT 189.4m / Capital Employed (Total Assets 801.6m - Current Liab 72.8m))
RoIC = 26.01% (NOPAT 137.5m / Invested Capital 528.8m)
WACC = 8.97% (E(3.28b)/V(3.42b) * Re(9.34%) + D(140.3m)/V(3.42b) * Rd(0.36%) * (1-Tc(0.27)))
Discount Rate = 9.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.91%
Fair Price DCF = unknown (Cash Flow -94.0m)
EPS Correlation: -46.25 | EPS CAGR: -6.45% | SUE: 0.0 | # QB: 0
Revenue Correlation: 10.43 | Revenue CAGR: -1.84% | SUE: 2.84 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.78 | Chg30d=-0.035 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=3.34 | Chg30d=-0.070 | Revisions Net=-1 | Growth EPS=+8.0% | Growth Revenue=+7.5%
EPS next Year (2027-12-31): EPS=3.70 | Chg30d=+0.032 | Revisions Net=-1 | Growth EPS=+10.8% | Growth Revenue=+8.9%

Additional Sources for CNS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle